SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

• Main Authors: Nanjing Shi (Author), Yetan Shi (Author), Jingsi Xu (Author), Yuexiu Si (Author), Tong Yang (Author), Mengting Zhang (Author), Derry Minyao Ng (Author), Xiangyuan Li (Author), Fei Xie (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Currently, the association between sodium-glucose cotransporter 2 inhibitor (SGLT-2i) and malignancy risk has yet to be fully elucidated. This meta-analysis aimed to determine the relationship between SGLT-2i and malignancy risk in type 2 diabetes (T2D) patients.Methods: We searched PubM...